deltatrials

Geographic atrophy Trials in Beverly Hills, United States

Conditions / Geographic atrophy / Beverly Hills, United States

Clinical trials for Geographic atrophy investigate a range of treatment strategies and patient populations.

28 total trials for this combination

Showing top 10 of 28 trials

Trials

NCT ID Title Status Phase
NCT03894020 GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) TERMINATED
NCT03525613 A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration COMPLETED PHASE3
NCT04435366 A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) COMPLETED PHASE3
NCT05019521 A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration TERMINATED PHASE2
NCT04465955 A Study of NGM621 in Participants With Geographic Atrophy COMPLETED PHASE2
NCT02745119 Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) TERMINATED PHASE3
NCT06510816 A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) ACTIVE_NOT_RECRUITING PHASE3
NCT03815825 GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) COMPLETED PHASE2
NCT03525600 Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration COMPLETED PHASE3
NCT02247479 A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration TERMINATED PHASE3

Related Pages